Aeglea BioTherapeutics Inc. (AGLE) fell -7.76% or -0.61 to $7.25. It is near to 104074 shares traded, which is 96.16% compare to the average total volume 108231. The market cap of AGLE is $173.73 million. The year to date change is 38.34%. The 52 week price range is from $4.86 to $12.0. Price of AGLE have changed -3.20% during last week. It have changed -0.38% over last month, -6.76% over last 3 months, -27.82% over last 6 months and 56.89% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AGLE is 8.64. It is 19.17% above current price. The 200-day Moving Averages for AGLE is 9.30. It is 28.28% above current price. The 52-week High is 12.0. It is 65.52% from the current price. The 52-week Low is 4.86. It is -32.97% from current price.
There are some statistics of AGLE. It is has market cap $173.73 million. The share outstanding is 23.96 million. The average volume is 108231. The percent of top 15 Institution holding is 71.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AGLE is -60.30%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AGLE is -54.54%.